Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus.
Hum Gene Ther. 2004 May;15(5):421-31. doi: 10.1089/10430340460745757.
Hum Gene Ther. 2004.
PMID: 15144573
Clinical Trial.
Clinical protocol. A phase II study: efficacy of the gene therapy of the MVA E2 recombinant virus in the treatment of precancerous lesions (NIC I and NIC II) associated with infection of oncogenic human papillomavirus.
Corona Gutierrez CM, Tinoco A, López Contreras M, Navarro T, Calzado P, Vargas L, Reyes L, Posternak R, Rosales R.
Corona Gutierrez CM, et al. Among authors: posternak r.
Hum Gene Ther. 2002 Jun 10;13(9):1127-40. doi: 10.1089/104303402753812520.
Hum Gene Ther. 2002.
PMID: 12067445
Clinical Trial.
No abstract available.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.